To determine aggregation, conjugates were analyzed by size-exclusion chromatography (SEC) (column: TSKgel G3000SWxl 7.8 mm × 30 cm, 5 μm (Tosoh Bioscience; P/N: 08541)) using 0.2 M sodium phosphate 0.2 M potassium chloride, pH 6.5 with 15% (v/v) isopropyl alcohol as mobile phase. An injection volume of 10 μL was loaded to the column at a constant flow rate of 0.35 mL/min. Chromatographs were integrated based on elution time to calculate the purity of monomeric conjugate species.
The drug-to-antibody ratio (DAR) was evaluated by HIC on a high-performance liquid chromatography (HPLC) system (Agilent 1260 HPLC system, TSKgel Butyl-NPR column 4.6 mm × 3.5 cm, 2.5 μm (Tosoh Bioscience; P/N: 14947)). The HIC method used 1.5 M ammonium sulfate in 25 mM potassium phosphate pH 7.0 (mobile phase A) and 25 mM potassium phosphate pH 7.0 containing 25% isopropanol v/v (mobile phase B) run at a flow rate of 0.8 mL/min over a 12-min linear gradient with UV monitoring at 254 and 280 nm.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.